Core Viewpoint - Lepu Medical's stock closed at 18.07 yuan, down 2.27%, with a rolling PE ratio of 236.64 times, significantly higher than the industry average of 59.49 times [1] Company Summary - Lepu Medical's main business includes medical devices, pharmaceuticals, medical services, and health management [1] - The latest quarterly report for Q1 2025 shows revenue of 1.736 billion yuan, a year-on-year decrease of 9.67%, and a net profit of 379 million yuan, down 21.44%, with a gross profit margin of 64.03% [1] Shareholder Information - As of March 31, 2025, Lepu Medical had 94,228 shareholders, an increase of 583 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Summary - The average PE ratio for the medical device industry is 59.49 times, with a median of 40.19 times, placing Lepu Medical at the 115th position in the industry ranking [2]

Group 1 - The core viewpoint of the news highlights that Lepu Medical's stock closed at 15.15 yuan, with a PE ratio of 198.40, marking a new low in 12 days, and a total market capitalization of 28.491 billion yuan [1] - The average PE ratio for the medical device industry is 54.55, with a median of 37.54, positioning Lepu Medical at 113th place in the industry ranking [1] - On July 24, Lepu Medical experienced a net outflow of 67.7061 million yuan in main funds, continuing a trend of outflows over the past five days, totaling 12.1149 million yuan [1] Group 2 - Lepu Medical's main business includes medical devices, pharmaceuticals, medical services, and health management [1] - The latest quarterly report for Q1 2025 shows that the company achieved an operating income of 1.736 billion yuan, a year-on-year decrease of 9.67%, and a net profit of 379 million yuan, down 21.44%, with a gross profit margin of 64.03% [1] - The PE ratios for other companies in the medical device industry range from 11.10 to 19.98, with Lepu Medical significantly higher than the industry average [2]

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Lepu Medical, indicating a significant disparity between its price-to-earnings (PE) ratio and the industry average [1][2] - Lepu Medical's closing stock price is 15.03 yuan, with a PE ratio of 196.83, which is substantially higher than the industry average of 52.19 and the median of 37.18 [1][2] - As of the first quarter of 2025, Lepu Medical reported a revenue of 1.736 billion yuan, reflecting a year-on-year decrease of 9.67%, and a net profit of 379 million yuan, down 21.44% year-on-year, with a gross margin of 64.03% [1] Group 2 - The total market capitalization of Lepu Medical is 28.266 billion yuan, with 17 institutions holding shares, including 12 funds, totaling 601.9932 million shares valued at 6.875 billion yuan [1] - The company operates in the medical device, pharmaceutical, medical services, and health management sectors, with its main products being medical devices and pharmaceuticals [1]

Company Overview - Lepu Medical's closing price on July 2 was 15.43 yuan, an increase of 4.05%, with a rolling PE ratio of 202.06, marking a new low in 249 days, and a total market capitalization of 29.018 billion yuan [1] - The company's main business includes medical devices, pharmaceuticals, medical services, and health management [1] Financial Performance - For Q1 2025, Lepu Medical reported revenue of 1.736 billion yuan, a year-on-year decrease of 9.67%, and a net profit of 379 million yuan, down 21.44% year-on-year, with a gross profit margin of 64.03% [1] Shareholder Information - As of March 31, 2025, Lepu Medical had 94,228 shareholders, an increase of 583 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 51.29, with a median of 37.02, placing Lepu Medical at 113th in the industry ranking [1][2] - The static PE ratio for Lepu Medical is 117.51, and the price-to-book ratio is 1.88 [2]

最新一期业绩显示，2025年一季报，公司实现营业收入17.36亿元，同比-9.67%；净利润3.79亿元，同 比-21.44%，销售毛利率64.03%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13乐普医疗170.5099.161.59244.86亿行业平均 49.4547.484.57105.42亿行业中值35.9237.582.3948.69亿1英科医疗9.6210.370.86152.00亿2九安医疗 10.1110.220.80170.60亿3新华医疗14.2313.191.1691.24亿4奥美医疗14.7414.451.5253.26亿5康德莱 15.1015.111.2532.54亿6振德医疗15.5614.670.9956.49亿7山东药玻15.7915.831.81149.31亿8维力医疗 15.9016.531.8636.26亿9九强生物16.1315.001.9879.89亿10奥泰生物16.4417.331.3352.42亿11安杰思 17.3517.562.1051.52亿12三鑫医疗18.0918.102.9841.16亿 来源：金融界 6月26日，乐普医疗今日收盘1 ...

6月10日，乐普医疗今日收盘13.47元，上涨4.10%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到176.40倍，总市值253.32亿元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)113乐普医疗176.40102.581.64253.32亿行业平均 51.0048.824.68108.70亿行业中值37.0337.302.5049.80亿1天益医疗-1801.27-3085.371.9222.95亿2澳华内 镜-688.49345.315.5272.56亿3诺唯赞-425.24-502.942.3391.00亿4爱朋医疗-416.91316.735.0234.21亿5博晖 创新-341.86542.483.6550.16亿6奥精医疗-150.60-220.731.9927.95亿7硕世生物-144.86-2116.821.3042.37亿 8睿昂基因-104.65-85.921.4813.55亿9康泰医学-87.91-74.273.1457.86亿10中红医疗-73.24-58.410.9350.90亿 11热景生物-66.56-76.694.91146.48亿 从行业市盈率 ...

Company Overview - Lepu Medical's closing price on May 28 was 11.12 yuan, down 1.42%, with a rolling PE ratio of 145.62 times and a total market value of 20.912 billion yuan [1] - The company operates in the medical device, pharmaceutical, medical services, and health management sectors, with its main products being medical devices, pharmaceuticals, and health management services [1] Financial Performance - For Q1 2025, Lepu Medical reported revenue of 1.736 billion yuan, a year-on-year decrease of 9.67%, and a net profit of 379 million yuan, down 21.44% year-on-year, with a gross profit margin of 64.03% [1] Shareholder Information - As of March 31, 2025, Lepu Medical had 94,228 shareholders, an increase of 583 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 48.81 times, with a median of 35.46 times, placing Lepu Medical at the 113th position in the industry ranking [2]

最新一期业绩显示，2025年一季报，公司实现营业收入17.36亿元，同比-9.67%；净利润3.79亿元，同 比-21.44%，销售毛利率64.03%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)110乐普医疗147.5985.831.38211.94亿行业平均 49.4645.354.63105.58亿行业中值36.1637.372.5047.48亿1天益医疗-1720.32-2946.711.8421.92亿2澳华内 镜-597.76299.814.7963.00亿3诺唯赞-409.62-484.482.2587.66亿4爱朋医疗-360.69274.024.3429.60亿5博晖 创新-322.93512.443.4547.38亿6硕世生物-134.71-1968.471.2139.40亿7奥精医疗-119.67-175.401.5822.21亿 8睿昂基因-100.21-82.271.4212.97亿9康泰医学-86.02-72.673.0756.61亿10中红医疗-69.48-55.420.8848.28亿 11华大智造-62.11-55.114.28331.13亿 来源：金融界 从行业 ...

Group 1 - The core viewpoint of the articles highlights that Lepu Medical's stock closed at 11.41 yuan, with a PE ratio of 149.42, marking a new low in 20 days, and a total market capitalization of 21.458 billion yuan [1] - The average PE ratio for the medical device industry is 48.90, with a median of 36.41, positioning Lepu Medical at the 111th rank within the industry [1] - As of March 31, 2025, Lepu Medical has 94,228 shareholders, an increase of 583 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 2 - Lepu Medical's main business includes medical devices, pharmaceuticals, medical services, and health management, with its primary products being in these categories [1] - The latest quarterly report for Q1 2025 shows that the company achieved a revenue of 1.736 billion yuan, a year-on-year decrease of 9.67%, and a net profit of 379 million yuan, down 21.44%, with a gross profit margin of 64.03% [1] - The PE ratios for Lepu Medical are significantly higher than the industry averages, indicating potential overvaluation compared to peers [2]